ELI
BMY icon

Empire Life Investments’s Bristol-Myers Squibb BMY Stock Holding History

Empire Life Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-489,767
Closed -$20.3M – 98
2024
Q2 		$20.3M Sell
489,767
-27,790
-5% -$1.24M 1.28% 31
2024
Q1 		$28.1M Sell
517,557
-16,307
-3% -$831K 1.72% 19
2023
Q4 		$27.4M Sell
533,864
-285
-0.1% -$15K 1.77% 20
2023
Q3 		$31M Sell
534,149
-1,123
-0.2% -$68.8K 2.27% 15
2023
Q2 		$34.2M Buy
535,272
+3,811
+0.7% +$256K 2.34% 16
2023
Q1 		$36.8M Sell
531,461
-1,621
-0.3% -$114K 2.62% 11
2022
Q4 		$38.4M Buy
533,082
+171,129
+47% +$12.9M 2.63% 14
2022
Q3 		$25.7M Buy
361,953
+8,582
+2% +$623K 1.96% 20
2022
Q2 		$27.2M Sell
353,371
-119,522
-25% -$9.1M 1.96% 19
2022
Q1 		$34.5M Sell
472,893
-346
-0.1% -$23.2K 2.21% 14
2021
Q4 		$29.5M Buy
473,239
+68,423
+17% +$4.01M 1.8% 23
2021
Q3 		$24M Sell
404,816
-2,226
-0.5% -$147K 1.57% 26
2021
Q2 		$27.2M Buy
407,042
+12,947
+3% +$844K 1.75% 24
2021
Q1 		$24.9M Buy
394,095
+109,859
+39% +$6.84M 1.71% 24
2020
Q4 		$17.6M Buy
+284,236
New +$17.5M 1.25% 29
2020
Q1 		– Sell
-1,190
Closed -$76K – 109
2019
Q4 		$76K Buy
+1,190
New +$68.2K 0.01% 96
2017
Q4 		– Sell
-61,045
Closed -$3.89M – 101
2017
Q3 		$3.89M Buy
61,045
+494
+0.8% +$28.8K 0.31% 79
2017
Q2 		$3.37M Hold
60,551
– – 0.29% 75
2017
Q1 		$3.29M Buy
60,551
+8,499
+16% +$466K 0.32% 70
2016
Q4 		$2.96M Buy
+52,052
New +$2.85M 0.24% 69

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Empire Life Investments's BMY Position: Q3 2024 in Review

Empire Life Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 489,767 shares — an estimated $20.3M sold.

Empire Life Investments first reported a position in BMY in Q4 2016 and held it in 20 quarters. The position peaked at $38.4M in Q4 2022. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Empire Life Investments reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Empire Life Investments sold 489,767 Bristol-Myers Squibb shares in Q3 2024, an estimated $20.3M.
  • Empire Life Investments first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 20 quarters.
  • Empire Life Investments's Bristol-Myers Squibb position peaked at $38.4M in Q4 2022.
  • 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Empire Life Investments's 13F filing for Q3 2024, filed 29 Oct 2024.